| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |